콘텐츠로 건너뛰기
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Menu
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Get In Touch
PharmCADD accomplished funding and strategic alliances with Huons and other biopharmaceutical companies.
News
12/17/2020
<View Original Article>
Prev
Previous
PharmCADD’s mRNA vaccine candidate showed reliable immunogenicity in animal model
Next
PharmCADD will create an innovative AI drug and will be listed on KOSDAQ in March 2022.
Next